J C Souto|J Fontcuberta - JoVE Visualize

Showing results (51-60 of 130) with videos related to

Pageof 13

Sort By:

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1995

Presentation of an acquired factor VIII inhibitor with a muscular haematoma mimicking a deep venous thrombosis in a patient with breast cancerR López, J Mateo, J Cruz, et al.

Haematologica|April 5, 2007

An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patientD Llobet, M Borrell, Ll Vila, et al.

Nouvelle Revue Francaise D'Hematologie|January 1, 1985

[Severe early-onset thrombopenia induced by non-fractionated heparin: therapeutic trial with low molecular weight heparin]E Grau, J Fontcuberta, R Martinez, et al.

Thrombosis Research|April 1, 1995

Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)--a three way cross-over study in healthy volunteersL Falkon, D Sáenz-Campos, R Antonijoan, et al.

Human Genetics|November 1, 1993

Acceptor splice site mutation in the invariant AG of intron 5 of the protein C gene, causing type I protein C deficiencyJ M Soria, J Fontcuberta, M Chillón, et al.

American Journal of Perinatology|March 26, 1998

Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardationJ Bellart, R Gilabert, J Fontcuberta, et al.

American Journal of Perinatology|October 27, 1998

Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetesJ Bellart, R Gilabert, J Fontcuberta, et al.

Medicina Clinica|November 21, 1992

[Polymorphism MI detected through the enzyme MspI in the study of congenital protein C deficiency]J M Soria, I Ibáñez, J Fontcuberta, et al.

Journal of Perinatal Medicine|January 1, 1997

Fibrinolysis changes in normal pregnancyJ Bellart, R Gilabert, J Fontcuberta, et al.

Thrombosis and Haemostasis|September 7, 1992

Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cellsM Borrell, N Sala, C de Castellarnau, et al.

Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:

Pageof 13

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1995

Presentation of an acquired factor VIII inhibitor with a muscular haematoma mimicking a deep venous thrombosis in a patient with breast cancerR López, J Mateo, J Cruz, et al.

Haematologica|April 5, 2007

An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patientD Llobet, M Borrell, Ll Vila, et al.

Nouvelle Revue Francaise D'Hematologie|January 1, 1985

[Severe early-onset thrombopenia induced by non-fractionated heparin: therapeutic trial with low molecular weight heparin]E Grau, J Fontcuberta, R Martinez, et al.

Thrombosis Research|April 1, 1995

Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)--a three way cross-over study in healthy volunteersL Falkon, D Sáenz-Campos, R Antonijoan, et al.

Human Genetics|November 1, 1993

Acceptor splice site mutation in the invariant AG of intron 5 of the protein C gene, causing type I protein C deficiencyJ M Soria, J Fontcuberta, M Chillón, et al.

American Journal of Perinatology|March 26, 1998

Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardationJ Bellart, R Gilabert, J Fontcuberta, et al.

American Journal of Perinatology|October 27, 1998

Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetesJ Bellart, R Gilabert, J Fontcuberta, et al.

Medicina Clinica|November 21, 1992

[Polymorphism MI detected through the enzyme MspI in the study of congenital protein C deficiency]J M Soria, I Ibáñez, J Fontcuberta, et al.

Journal of Perinatal Medicine|January 1, 1997

Fibrinolysis changes in normal pregnancyJ Bellart, R Gilabert, J Fontcuberta, et al.

Thrombosis and Haemostasis|September 7, 1992

Immunoglobulin fractions isolated from patients with antiphospholipid antibodies prevent the inactivation of factor Va by activated protein C on human endothelial cellsM Borrell, N Sala, C de Castellarnau, et al.

Pageof 13